#Yamato Transport #Alfresa #D-mobico

Innovative Collaboration to Improve Pharmaceutical Delivery

In response to extreme weather conditions that have become increasingly common in recent years, Alfresa Corporation and Yamato Transport have initiated a groundbreaking trial for the delivery of pharmaceuticals using small electric vehicles (EVs) and insulated transport equipment. This effort aims to ensure that medicines are safely and reliably transported even during the hottest summer months.

Overview of the Trial

The rising heat waves that accompany abnormal climate changes have made temperature management for pharmaceuticals a critical issue. Concurrently, the pharmaceutical delivery sector faces urgent pressures to decarbonize. Establishing a sustainable distribution network that maintains optimal temperatures for medicines while being environmentally friendly is now more important than ever.

Through this trial, Alfresa aims to examine potential data gathered to assess the viability of integrating specific equipment and delivery operations. The 'D-mobico', an EV-powered mobile cooling unit, is already in operational use, and plans are being considered for enhancements that include an energy management system (EMS) and solar power installations to cover the energy consumption with renewable sources. Furthermore, the Yamato group is reviewing the inclusion of these devices in their